Meeting ReportOncology, Basic and Translational - In vitro and In vivo Oncology

Heterogeneity of sodium iodide symporter (NIS) expression in thyroid cancer impairs therapeutic efficacy: An in vitro study

Hiroki Tanaka, Sho Koyasu, Yoichi Shimizu, Tadashi Watabe, Kazuko Kaneda-Nakashima, Makoto Hosono and Yuji Nakamoto
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P511;

Article Information

vol. 64 no. supplement 1 P511
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.
Copyright & Usage 
© 2023

Author Information

  1. Hiroki Tanaka1,
  2. Sho Koyasu2,
  3. Yoichi Shimizu,
  4. Tadashi Watabe3,
  5. Kazuko Kaneda-Nakashima4,
  6. Makoto Hosono5 and
  7. Yuji Nakamoto
  1. 1Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University
  2. 2KYOTO UNIVERSITY
  3. 3Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine
  4. 4Institute for Radiation Sciences, Osaka University
  5. 5Kindai University Faculty of Medicine

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023300
Sep 20231400
Oct 20232100
Nov 20233300
Dec 20232600
Jan 20241300
Feb 20241300
Mar 20242500
Apr 20245000
May 20241500
Jun 20244600
Jul 202410400
Aug 20248800
Sep 20241300
Oct 20241700
Nov 20241700
Dec 20241000
Jan 2025900
Feb 20251100
Mar 2025800
Apr 20251600
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section